

Report to Congress: Prescription Drugs: Innovation, Spending, and Patient Access
This Report responded to a request from the House and Senate Committees on Appropriations. Published estimates of the cost of new drug development range from $1.2 billion to $2.6 billion and are highly sensitive to assumptions about pre-clinical and clinical development time, cost of capital, the likelihood of reaching approval following the start
DrugPricingRTC2016.pdf